NCT05389423
- Conditions
- B-Cell Neoplasm, Burkitt Lymphoma, DNA Virus Infections, +19 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Clinical trial condition
B-Cell Neoplasm
Explore clinical trials studying B-Cell Neoplasm. Study availability and eligibility vary by location and protocol.
6 public trials
2 recruiting studies
B-Cell Neoplasm trial results
NCT06508931
- Conditions
- B-Cell Neoplasm, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- Hôpital Robert Debré Paris, Boulevard Sérurier 48, France
- Institut Gustave Roussy Villejuif, France
- Universitaetsklinikum Muenster (UKM) - Klinik fuer Kinder- und Jugendmedizin - Paediatrische Haematologie und Onkologie Münster, Albert-Schweitzer-Campus 1, Gebaeude A1, Germany
- IRCCS Ospedale Pediatrico Bambino Gesù Rome, Piazza Sant Onofrio 4, Italy
Not Yet Recruiting
Systemic Inflammatory Markers in B-cell Neoplasm
NCT06847529
- Conditions
- B-Cell Neoplasm, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- Assiut University Asyut, Egypt
NCT04410900
- Conditions
- B-Cell Neoplasm, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT02599194
- Conditions
- Adenocarcinoma, Adenoma, B-Cell Neoplasm, +53 more
- Locations
-
- Stanford University Medical Center Stanford, California, United States
Active, Not Recruiting
Lenalidomide Combined With Modified DA-EPOCH and Rituximab (EPOCH-R2) in Primary Effusion Lymphoma or KSHV-associated Large Cell Lymphoma
NCT02911142
- Conditions
- B-Cell Neoplasm, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States